Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-12-01

著者

• Kato Norihiko

  Department Of Orthopaedic Surgery Heisei Memorial Hospital

• Kato Norihiko

  Department Of Mechanical Eng Mie University

• Kobayashi Hayato

  Department Of Orthopaedic Surgery Heisei Memorial Hospital

• Kageyama Yasunori

  Department Of Orthopaedic Surgery Hamamatsu University School Of Medicine

• Kageyama Yasunori

  Department Of Orthopaedic Surgery Heisei Memorial Hospital

関連論文

• Comparison between resection arthroplasty alone and resection arthroplasty with arthrodesis of the first MTP joint for rheumatoid forefoot deformities
• Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis
• The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis
• Osteoma Arising From the Lumbar Articular Process : Case Report
• Reduction of bone mineral density in rheumatoid arthritis: A longitudinal study
• IM-08 A BASIC STUDY ON A FACE-TO-FACE IMAGE PRESENTATION SYSTEM
• Path Planning Algorithm-How to Evaluate the Difficulties of Moving in Various Environment
• Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
• Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis

スポンサーリンク